(Q57084702)
Statements
The anti-Parkinsonian drug selegiline delays the nucleation phase of α-synuclein aggregation leading to the formation of nontoxic species (English)
Cristian Follmer
Elias Khattar
Luciana Romão
Saviana Di Giovanni
Carolina A Braga
Mônica S Freitas